# Tandem Control-IQ Evaluation Regarding Glucose Metrics, Sleep, and Health Economics

> **NCT05969106** · — · COMPLETED · sponsor: **Vastra Gotaland Region** · enrollment: 84 (actual)

## Conditions studied

- Type 1 Diabetes

## Interventions

- **DEVICE:** Tandem Control-IQ

## Key facts

- **NCT ID:** NCT05969106
- **Lead sponsor:** Vastra Gotaland Region
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-01-01
- **Primary completion:** 2022-12-30
- **Final completion:** 2022-12-30
- **Target enrollment:** 84 (ACTUAL)
- **Last updated:** 2023-08-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05969106

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05969106, "Tandem Control-IQ Evaluation Regarding Glucose Metrics, Sleep, and Health Economics". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05969106. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*